Pfizer starting study of vaccine geared toward Omicron variant
Pfizer has begun a study evaluating its unique COVID-19 vaccine with doses specifically tweaked to match the vastly contagious Omicron variant. Pfizer and its associate...
Pfizer has begun a study evaluating its unique COVID-19 vaccine with doses specifically tweaked to match the vastly contagious Omicron variant. Pfizer and its associate...
COVID-19 sufferers in Wyoming desperate to get their hands on Pfizer's new antiviral tablet for treating the illness might need to draw straws. With provides...
As instances of the Omicron variant proceed to rise throughout the U.S., public well being officers have one essential query: Are the present COVID-19 vaccines...
Pfizer mentioned Friday that it could produce a COVID-19 vaccine for the new virus strain recognized in South Africa in "approximately 100 days," topic to authorities regulatory...
The U.S. authorities can pay drugmaker Pfizer practically $5.3 billion for 10 million treatment programs of its potential COVID-19 treatment if regulators approve it. Pfizer requested...
Pfizer is asking federal regulators to authorize its experimental COVID-19 pill, which the drugmaker says can defend folks from probably the most extreme signs of the...
Pfizer and BioNTech said Thursday {that a} late-stage trial of the drugmakers' COVID-19 vaccine booster confirmed it restored full protection against the illness. In a check involving 10,000 contributors,...
(*11*)Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11 -- and if regulators agree, shots might start inside a matter...